[go: up one dir, main page]

AU1285499A - Somatostatin agonists - Google Patents

Somatostatin agonists

Info

Publication number
AU1285499A
AU1285499A AU12854/99A AU1285499A AU1285499A AU 1285499 A AU1285499 A AU 1285499A AU 12854/99 A AU12854/99 A AU 12854/99A AU 1285499 A AU1285499 A AU 1285499A AU 1285499 A AU1285499 A AU 1285499A
Authority
AU
Australia
Prior art keywords
somatostatin agonists
somatostatin
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12854/99A
Inventor
Liangqin Guo
Ralph T. Mosley
Alexander Pasternak
Arthur A. Patchett
Lihu Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806697.0A external-priority patent/GB9806697D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU1285499A publication Critical patent/AU1285499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12854/99A 1997-10-30 1998-10-28 Somatostatin agonists Abandoned AU1285499A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6442297P 1997-10-30 1997-10-30
US60064422 1997-10-30
GB9806697 1998-03-27
GBGB9806697.0A GB9806697D0 (en) 1998-03-27 1998-03-27 Somatostatin agonists
PCT/US1998/022917 WO1999022735A1 (en) 1997-10-30 1998-10-28 Somatostatin agonists

Publications (1)

Publication Number Publication Date
AU1285499A true AU1285499A (en) 1999-05-24

Family

ID=26313387

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12854/99A Abandoned AU1285499A (en) 1997-10-30 1998-10-28 Somatostatin agonists

Country Status (2)

Country Link
AU (1) AU1285499A (en)
WO (1) WO1999022735A1 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4679778B2 (en) * 1999-07-13 2011-04-27 メルク・シャープ・エンド・ドーム・コーポレイション Enhancement of growth hormone release by amidospiropiridines.
CA2316767A1 (en) * 1999-09-01 2001-03-01 Bridget Mccarthy Cole Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
US6696418B1 (en) 1999-09-01 2004-02-24 Pfizer Inc. Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
FR2802206B1 (en) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic 4-AMINOPIPERIDINE DERIVATIVES AND THEIR USE AS MEDICINAL PRODUCTS
US6495589B2 (en) 2000-04-28 2002-12-17 Pfizer Inc. Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
US6720330B2 (en) 2000-11-17 2004-04-13 Pfizer Inc. Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
PL367983A1 (en) * 2001-08-07 2005-03-21 Banyu Pharmaceutical Co, Ltd. Spiro compounds
WO2003057214A1 (en) 2001-12-28 2003-07-17 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
US7960369B2 (en) 2002-11-08 2011-06-14 Takeda Pharmaceutical Company Limited Receptor function regulator
DE10308356A1 (en) * 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Cycloalkyl substituted alkanoic acid derivatives, process for their preparation and their use as medicaments
WO2004093807A2 (en) 2003-04-22 2004-11-04 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin vectors
GEP20084570B (en) 2003-10-31 2008-12-25 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
WO2005095338A1 (en) 2004-03-30 2005-10-13 Takeda Pharmaceutical Company Limited Alkoxyphenylpropanoic acid derivatives
EP1873144B1 (en) 2005-04-20 2014-07-23 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
JP5000490B2 (en) 2005-04-28 2012-08-15 武田薬品工業株式会社 Thienopyrimidone compounds
JP5044398B2 (en) 2005-06-09 2012-10-10 武田薬品工業株式会社 Solid preparation
JP2007063225A (en) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd Imidazopyridine compound
MY146564A (en) 2005-11-10 2012-08-30 Msd Kk Aza-substituted spiro derivatives
US20090042863A1 (en) 2005-12-28 2009-02-12 Takeda Pharmaceutical Company Limited Therapeutic Agent for Diabetes
RS53230B (en) 2006-06-27 2014-08-29 Takeda Pharmaceutical Company Limited Fused cyclic compounds as gpr40 receptor modulators
WO2008016131A1 (en) 2006-08-04 2008-02-07 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
BRPI0719060A2 (en) 2006-11-24 2014-02-04 Takeda Pharmaceutical COMPOUND, PRODUCT, PHARMACEUTICAL AGENT, METHODS TO INHIBIT AN ANGIOTENSIN II RECEIVER AND / OR ACTIVATE A PEROXISOMAL ACTIVATED RECEIVER, AND TO PREVENT OR TREAT DISEASE OR CONDITION, AND, USE OF A COMPOUND
ES2385114T3 (en) 2007-03-30 2012-07-18 Ambrx, Inc. Modified FGF-21 polypeptides and their uses
US8318746B2 (en) 2007-04-27 2012-11-27 Takeda Pharmaceutical Company Limited Nitrogen-containing five-membered heterocyclic compound
WO2008143262A1 (en) 2007-05-21 2008-11-27 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
TW200914006A (en) 2007-07-12 2009-04-01 Takeda Pharmaceutical Coated preparation
EP2264017A4 (en) 2008-04-04 2011-07-27 Takeda Pharmaceutical HETEROCYCLIC DERIVATIVE AND USE THEREOF
US8349886B2 (en) 2008-04-16 2013-01-08 Takeda Pharmaceutical Company Limited Nitrogenated 5-membered heterocyclic compound
WO2010016552A1 (en) 2008-08-07 2010-02-11 武田薬品工業株式会社 Therapeutic agent for irritable bowel syndrome
US9464075B2 (en) 2008-09-16 2016-10-11 The Trustees Of The University Of Pennsylvania Influenza A virus inhibition
EP2382218A1 (en) 2009-01-27 2011-11-02 Takeda Pharmaceutical Company Limited Delta-5-desaturase inhibitors
CA2758895A1 (en) 2009-04-16 2010-10-21 Takeda Pharmaceutical Company Limited Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
JP2010254623A (en) 2009-04-24 2010-11-11 Takeda Chem Ind Ltd Crystal of benzoxazinone compound
US9301950B2 (en) 2009-08-21 2016-04-05 The Trustees Of The University Of Pennsylvania Adamantane analogs
US8440720B2 (en) 2009-09-11 2013-05-14 Influmedix, Inc. Methods of use of antiviral compounds
WO2011151782A1 (en) 2010-06-02 2011-12-08 Preglem Sa A role for somatostatin to modulate initiation of follicular growth in the human ovary
EA026142B1 (en) 2010-07-23 2017-03-31 Такеда Фармасьютикал Компани Лимитед Fused heterocyclic compound and application thereof
US9884832B2 (en) 2011-12-06 2018-02-06 The Trustees Of The University Of Pennsylvania Inhibitors targeting drug-resistant influenza A
US9630976B2 (en) 2012-07-03 2017-04-25 Ono Pharmaceutical Co., Ltd. Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes
CN104755465A (en) 2012-08-24 2015-07-01 武田药品工业株式会社 Heterocycic compound
WO2014070965A2 (en) 2012-11-01 2014-05-08 Ipsen Pharma S.A.S Somatostatin analogs and dimers thereof
TWI523863B (en) 2012-11-01 2016-03-01 艾普森藥品公司 Somatostatin-dopamine chimeric analogs
US9643951B2 (en) 2013-09-30 2017-05-09 Ono Pharmaceutical Co., Ltd. Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof
EP3209316A2 (en) 2014-10-24 2017-08-30 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
SG11201702312UA (en) 2014-10-24 2017-05-30 Takeda Pharmaceuticals Co Heterocyclic compound
SG11201907240XA (en) 2017-02-08 2019-09-27 Ono Pharmaceutical Co Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof

Also Published As

Publication number Publication date
WO1999022735A1 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
AU1285499A (en) Somatostatin agonists
EP1023061A4 (en) Somatostatin agonists
EP0977751A4 (en) Somatostatin agonists
EP0984779A4 (en) Somatostatin agonists
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU4117497A (en) Micropolarimeter
AU6185898A (en) Clavaspirins
AU7761998A (en) Korrosionsschutzanstrichstoff
AU8214598A (en) 3-benzylpiperidine
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU8736698A (en) Shale-stabilizing additives
AU1505999A (en) Immunosuppressant agonists
AU8991998A (en) Renovative pipeliner
AU5391798A (en) Thiamacrolides
AU9183798A (en) Catamaran - bicycle - kayak
AU4469997A (en) Heregulin-gamma
AU7212698A (en) Substituted aryluracils
AU7530198A (en) Substituted 4-benzoyl-pyrazoles
AU7163598A (en) Aminotetralins as 5-ht1dalpha agonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase